Improved specificity and reduced subtype cross-reactivity for antibody detection by ELISA using globular head domain recombinant hemagglutinin

Journal of Virological Methods

Volumn 209, Issue , 2014, Pages 121-125

  Li, Zhu Nan ^a   Carney, Paul J ^a   Lin, Seh Ching ^b   Li, Ji ^a,c   Chang, Jessie C ^a   Veguilla, Vic ^a   Stevens, James ^a   Miller, Joseph D ^a   Levine, Min ^a   Katz, Jacqueline M ^a   Hancock, Kathy ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Ectodomain hemagglutinin; ELISA; Globular head domain HA; Influenza

Indexed keywords

ECTODOMAIN HEMAGGLUTININ; GLOBULAR HEAD DOMAIN HEMAGGLUTININ; HEMAGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; INFLUENZA A (H1N1); INFLUENZA A (H5N1); INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INTERMETHOD COMPARISON; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VERY ELDERLY; VIRUS DETECTION; BLOOD; DIAGNOSTIC TEST; DIAGNOSTIC USE; EVALUATION STUDY; FEMALE; HEAD; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; DIAGNOSTIC TESTS, ROUTINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HEMAGGLUTININS; HUMANS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84907810180     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.09.006     Document Type: Article

References (29)

1. Alvarez M.M., Lopez-Pacheco F., Aguilar-Yanez J.M., Portillo-Lara R., Mendoza-Ochoa G.I., Garcia-Echauri S., Freiden P., Schultz-Cherry S., Zertuche-Guerra M.I., Bulnes-Abundis D., Salgado-Gallegos J., Elizondo-Montemayor L., Hernandez-Torre M. Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method. PLoS One 2010, 5:e10176.
2. Arankalle V.A., Virkar R.G., Tandale B.V., Ingle N.B. Utility of pandemic H1N1 2009 influenza virus recombinant hemagglutinin protein-based enzyme-linked immunosorbent assay for serosurveillance. Clin. Vaccine Immunol. 2010, 17:1481-1483.
3. Broberg E., Nicoll A., Amato-Gauci A. Seroprevalence to influenza A(H1N1) 2009 virus-where are we?. Clin. Vaccine Immunol. 2011, 18:1205-1212.
4. Burlington D.B., Wright P.F., van Wyke K.L., Phelan M.A., Mayner R.E., Murphy B.R. Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children. J. Clin. Microbiol. 1985, 21:847-849.
5. Caton A.J., Brownlee G.G., Yewdell J.W., Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982, 31:417-427.
6. CDC National Health and Nutrition Examination Survey 2008, http://www.cdc.gov/nchs/nhanes.htm Accessed on April 15th, 2013.
7. DuBois R.M., Aguilar-Yanez J.M., Mendoza-Ochoa G.I., Oropeza-Almazan Y., Schultz-Cherry S., Alvarez M.M., White S.W., Russell C.J. The receptor-binding domain of influenza virus hemagglutinin produced in Escherichia coli folds into its native, immunogenic structure. J. Virol. 2011, 85:865-872.
8. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., Liu F., Dong L., DeVos J.R., Gargiullo P.M., Brammer T.L., Cox N.J., Tumpey T.M., Katz J.M. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. New Eng. J. Med. 2009, 361:1945-1952.
9. Katz J.M., Hancock K., Xu X. Serologic assays for influenza surveillance, diagnosis, and vaccine evaluation. Expert Rev. Anti Infect. Ther. 2011, 9:669-683.
10. Khurana S., Chearwae W., Castellino F., Manischewitz J., King L.R., Honorkiewicz A., Rock M.T., Edwards K.M., Del Giudice G., Rappuoli R., Golding H. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci. Transl. Med. 2010, 2(15):ra5.
11. Khurana S., Verma N., Yewdell J.W., Hilbert A.K., Castellino F., Lattanzi M., Del Giudice G., Rappuoli R., Golding H. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Sci. Transl. Med. 2011, 3(85):ra48.
12. Koopmans M., de Bruin E., Godeke G.J., Friesema I., van Gageldonk R., Schipper M., Meijer A., van Binnendijk R., Rimmelzwaan G.F., de Jong M.D., Buisman A., van Beek J., van de Vijver D., Reimerink J. Profiling of humoral immune responses to influenza viruses by using protein microarray. Eur. Soc. Clin. Microbiol. Infect. Dis. 2012, 18:797-807.
13. Krystal M., Elliott R.M., Benz E.W., Young J.F., Palese P. Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:4800-4804.
14. Laurie K.L., Huston P., Riley S., Katz J.M., Willison D.J., Tam J.S., Mounts A.W., Hoschler K., Miller E., Vandemaele K., Broberg E., Van Kerkhove M.D., Nicoll A. Influenza serological studies to inform public health action: best practices to optimise timing, quality, and reporting. Influenza Respir. Viruses 2013, 7:211-224.
15. Li Z.N., Lin S.C., Carney P.J., Li J., Liu F., Lu X., Liu M., Stevens J., Levine M., Katz J.M., Hancock K. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States. Clin. Vaccine Immunol. 2014, 21:1054-1060.
16. Maltezou H.C., Katerelos P., Mavrouli M., Lourida A., Routsias J.G., Spanakis N., Maragos A., Tedoma A., Bassiakos Y., Koratzanis G., Mantagos S., Metallidis S., Katragkou A., Nikolaidis P., Roilides E., Theodoridou M., Tsakris A. Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece. Vaccine 2011, 29:6664-6669.
17. Nobusawa E., Aoyama T., Kato H., Suzuki Y., Tateno Y., Nakajima K. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 1991, 182:475-485.
18. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., Fukuda K., Cox N.J., Katz J.M. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 1999, 37:937-943.
19. Staczek J., Gilleland H.E., Gilleland L.B., Harty R.N., Garcia-Sastre A., Engelhardt O.G., Palese P. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection. Infect. Immun. 1998, 66:3990-3994.
20. Stephenson I., Heath A., Major D., Newman R.W., Hoschler K., Junzi W., Katz J.M., Weir J.P., Zambon M.C., Wood J.M. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg. Infect. Dis. 2009, 15:1252-1259.
21. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., Wan H., Murakami A., Yammanuru A., Han T., Cox N.J., Bankston L.A., Donis R.O., Liddington R.C., Marasco W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 2009, 16:265-273.
22. Sullivan J.S., Selleck P.W., Downton T., Boehm I., Axell A.M., Ayob Y., Kapitza N.M., Dyer W., Fitzgerald A., Walsh B., Lynch G.W. Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture. J. Mol. Genet. Med. 2009, 3:217-224.
23. Tsuchiya E., Sugawara K., Hongo S., Matsuzaki Y., Muraki Y., Li Z.N., Nakamura K. Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus. J. Gen. Virol. 2001, 82:2475-2484.
24. Wiley D.C., Skehel J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 1987, 56:365-394.
25. Wood J.M., Major D., Heath A., Newman R.W., Hoschler K., Stephenson I., Clark T., Katz J.M., Zambon M.C. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine 2012, 30:210-217.
26. Yang H., Carney P., Stevens J. Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr. 2010, 2:RRN1152.
27. Yang H., Carney P.J., Chang J.C., Villanueva J.M., Stevens J. Structural analysis of the hemagglutinin from the recent 2013 H7N9 influenza virus. J. Virol. 2013, 87:12433-12446.
28. Yang H., Chang J.C., Guo Z., Carney P.J., Shore D.A., Donis R.O., Cox N.J., Villanueva J.M., Klimov A.I., Stevens J. Structural stability of influenza A(H1N1)pdm09 virus hemagglutinins. J. Virol. 2014, 88:4828-4838.
29. Zhao R., Cui S., Guo L., Wu C., Gonzalez R., Paranhos-Baccala G., Vernet G., Wang J., Hung T. Identification of a highly conserved h1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza a virus. PLoS One 2011, 6:e23374.